Sullivan Christopher Ryan Insider Trades

Insider Trading History

Track insider trading activity for Sullivan Christopher Ryan. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Financial Officer
Holding Value $751k 40,773 shares
Last Trade
Jun 10, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.81k 138 shares
$13.10
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Financial Officer
Holding Value $743k 40,323 shares
Last Trade
May 21, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$662k 39,900 shares
$16.60
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Financial Officer
Holding Value $3.1M 168,094 shares
Last Trade
May 07, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$426k 18,606 shares
$22.87
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Financial Officer
Holding Value $7.79k 423 shares
Last Trade
May 07, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$449k 18,606 shares
$24.12
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Financial Officer
Holding Value $351k 19,029 shares
Last Trade
May 07, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$426k 18,606 shares
$22.87
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Financial Officer
Holding Value $619k 33,589 shares
Last Trade
May 06, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$949k 47,000 shares
$20.19
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Financial Officer
Holding Value $874k 47,423 shares
Last Trade
May 06, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.03M 47,000 shares
$21.81
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Financial Officer
Holding Value $2.14M 116,000 shares
Last Trade
May 06, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.03M 47,000 shares
$21.81
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Financial Officer
Holding Value $7.79k 423 shares
Last Trade
Apr 30, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$112k 8,457 shares
$13.23
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Financial Officer
Holding Value $164k 8,880 shares
Last Trade
Apr 29, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$111k 8,458 shares
$13.09
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Financial Officer
Holding Value $352k 19,118 shares
Last Trade
Apr 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$137k 7,980 shares
$17.14
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Financial Officer
Holding Value $604k 32,797 shares
Last Trade
Apr 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$134k 7,979 shares
$16.77
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Financial Officer
Holding Value $765k 41,538 shares
Last Trade
Mar 28, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$336k 24,200 shares
$13.89
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Financial Officer
Holding Value $613k 33,297 shares
Last Trade
Mar 28, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$114k 8,241 shares
$13.89
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Financial Officer
Holding Value $446k 24,200 shares
Last Trade
Mar 28, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$336k 24,200 shares
$13.89
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Financial Officer
Holding Value $1.93M 105,000 shares
Last Trade
Feb 26, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.85M 105,000 shares
$17.64
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Financial Officer
Holding Value $319k 17,338 shares
Last Trade
Dec 10, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.09k 155 shares
$19.95
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Financial Officer
Holding Value $892k 48,400 shares
Last Trade
Mar 28, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$205k 24,200 shares
$8.46
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Financial Officer
Holding Value $312k 16,921 shares
Last Trade
Mar 28, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$61.6k 7,285 shares
$8.46
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Financial Officer
Holding Value $446k 24,206 shares
Last Trade
Mar 28, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$205k 24,200 shares
$8.46
$18.42

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up